• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评价聚(D,L-丙交酯-共-乙交酯)微球用于元胡碱肺部靶向给药的研究,元胡碱是一种新型的 DNA 拓扑异构酶 I 抑制剂。

Evaluation of poly(D,L-lactide-co-glycolide) microspheres for the lung-targeting of yuanhuacine, a novel DNA topoisomerase I inhibitor.

机构信息

State Key Laboratory of Fine Chemicals, School of Chemical Engineering, Dalian University of Technology, Dalian, People's Republic of China.

出版信息

J Drug Target. 2009 May;17(4):286-93. doi: 10.1080/10611860902737912.

DOI:10.1080/10611860902737912
PMID:19558356
Abstract

The present study was intended to develop poly(D,L-lactide-co-glycolide) (PLGA; 50:50, 0.15 dL/g) microspheres (MS) loaded with yuanhuacine (YHC) for passive targeting in lung as well as providing a simple evaluation method for the targeting efficiency of MS. A kind of photochromic spiropyran dye was applied to label MS to clearly demonstrate the in vivo distribution characteristics through intravenous injection into mice and rabbits. Sections of 10-microm thickness from different organs were cut using a microtome, and fluorescent microscopy was used to determine the biodistribution of the MS. The average particle size of MS was 9.0 microm, and the glass transition temperature was 37-40 degrees C. In vitro, the cumulative release achieved 50.8% in 24 h. Histological sections from different organs indicated that the amount of MS in lung achieved maximum in 6 h, as about 8 times as in liver and 70 times higher than the average concentration of other organs. In vivo, MS were gradually swelled and drug concentration remained just 10% in 12 h, which would not result in long time embolization in the lung. This evaluation method supplies a simple and visualized channel in focus for the targeting efficiency of PLGA MS.

摘要

本研究旨在制备载芫花素(YHC)的聚(D,L-丙交酯-共-乙交酯)(PLGA;50:50,0.15 dL/g)微球(MS),以被动靶向肺部,并提供一种简单的方法来评价 MS 的靶向效率。一种光致变色螺吡喃染料被应用于标记 MS,以便通过静脉注射到小鼠和兔体内,通过荧光显微镜清楚地显示其体内分布特征。使用切片机从不同器官切取 10 微米厚的切片,通过荧光显微镜确定 MS 的生物分布。MS 的平均粒径为 9.0 微米,玻璃化转变温度为 37-40 摄氏度。体外,在 24 小时内累积释放达到 50.8%。来自不同器官的组织学切片表明,MS 在肺中的含量在 6 小时达到最大值,约为肝脏的 8 倍,是其他器官平均浓度的 70 倍。体内,MS 逐渐肿胀,12 小时内药物浓度仅为 10%,不会在肺部造成长时间栓塞。这种评价方法为 PLGA MS 的靶向效率提供了一种简单直观的聚焦通道。

相似文献

1
Evaluation of poly(D,L-lactide-co-glycolide) microspheres for the lung-targeting of yuanhuacine, a novel DNA topoisomerase I inhibitor.评价聚(D,L-丙交酯-共-乙交酯)微球用于元胡碱肺部靶向给药的研究,元胡碱是一种新型的 DNA 拓扑异构酶 I 抑制剂。
J Drug Target. 2009 May;17(4):286-93. doi: 10.1080/10611860902737912.
2
Studies on the poly(lactic-co-glycolic) acid microspheres of cisplatin for lung-targeting.顺铂聚乳酸-羟基乙酸共聚物微球的肺靶向研究。
Int J Pharm. 2005 Jan 31;289(1-2):63-7. doi: 10.1016/j.ijpharm.2004.10.017. Epub 2004 Dec 19.
3
Preparation, characterization, and in vitro evaluation of physostigmine-loaded poly(ortho ester) and poly(ortho ester)/poly(D,L-lactide-co-glycolide) blend microspheres fabricated by spray drying.通过喷雾干燥制备的载毒扁豆碱聚原酸酯和聚原酸酯/聚(D,L-丙交酯-共-乙交酯)共混微球的制备、表征及体外评价
Biomaterials. 2004 Jul;25(16):3275-82. doi: 10.1016/j.biomaterials.2003.09.099.
4
Facile control of porous structures of polymer microspheres using an osmotic agent for pulmonary delivery.采用渗透压剂控制聚合物微球的多孔结构用于肺部给药。
J Control Release. 2010 Aug 17;146(1):61-7. doi: 10.1016/j.jconrel.2010.05.026. Epub 2010 May 26.
5
A novel trans-lymphatic drug delivery system: implantable gelatin sponge impregnated with PLGA-paclitaxel microspheres.一种新型经淋巴药物递送系统:负载聚乳酸-羟基乙酸共聚物-紫杉醇微球的可植入明胶海绵
Biomaterials. 2007 Jul;28(21):3236-44. doi: 10.1016/j.biomaterials.2007.03.022. Epub 2007 Mar 24.
6
Formulation and in vitro/in vivo evaluation of terbutaline sulphate incorporated in PLGA (25/75) and L-PLA microspheres.硫酸特布他林载入PLGA(25/75)和L - PLA微球的制剂及其体外/体内评价
J Microencapsul. 2003 Mar-Apr;20(2):261-71.
7
Incorporation and in vitro release of doxorubicin in thermally sensitive micelles made from poly(N-isopropylacrylamide-co-N,N-dimethylacrylamide)-b-poly(D,L-lactide-co-glycolide) with varying compositions.阿霉素在由不同组成的聚(N-异丙基丙烯酰胺-co-N,N-二甲基丙烯酰胺)-b-聚(D,L-丙交酯-co-乙交酯)制成的热敏胶束中的包封及体外释放
Biomaterials. 2005 Aug;26(24):5064-74. doi: 10.1016/j.biomaterials.2005.01.030.
8
New insights into the pore structure of poly(d,l-lactide-co-glycolide) microspheres.聚(D,L-丙交酯-共-乙交酯)微球的孔结构的新见解。
Int J Pharm. 2010 Dec 15;402(1-2):20-6. doi: 10.1016/j.ijpharm.2010.09.014. Epub 2010 Sep 29.
9
Enhanced targeting efficiency of PLGA microspheres loaded with Lornoxicam for intra-articular administration.载洛昔康 PLGA 微球经关节腔内给药后的靶向效率增强。
Drug Deliv. 2011 Sep-Oct;18(7):536-44. doi: 10.3109/10717544.2011.596584. Epub 2011 Aug 4.
10
Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.透明质酸锚定的阿霉素聚乳酸-羟基乙酸共聚物纳米颗粒载体的研制与表征
Nanomedicine. 2007 Dec;3(4):246-57. doi: 10.1016/j.nano.2007.09.004.

引用本文的文献

1
Yuanhuacin and Related Anti-Inflammatory and Anticancer Daphnane Diterpenes from Genkwa Flos-An Overview.芫花素及相关抗炎和抗癌瑞香烷二萜类化合物——Genkwa Flos 的概述。
Biomolecules. 2022 Jan 23;12(2):192. doi: 10.3390/biom12020192.
2
Lung-targeting drug delivery system of baicalin-loaded nanoliposomes: development, biodistribution in rabbits, and pharmacodynamics in nude mice bearing orthotopic human lung cancer.载黄芩苷纳米脂质体的肺靶向给药系统:研制、在兔体内的生物分布及对原位人肺癌裸鼠的药效学研究
Int J Nanomedicine. 2016 Dec 29;12:251-261. doi: 10.2147/IJN.S119895. eCollection 2017.
3
Anti-Tumor Activity of Yuanhuacine by Regulating AMPK/mTOR Signaling Pathway and Actin Cytoskeleton Organization in Non-Small Cell Lung Cancer Cells.
芫花酯甲通过调控非小细胞肺癌细胞中的AMPK/mTOR信号通路及肌动蛋白细胞骨架组织发挥抗肿瘤活性
PLoS One. 2015 Dec 11;10(12):e0144368. doi: 10.1371/journal.pone.0144368. eCollection 2015.
4
The Chinese herb isolate yuanhuacine (YHL-14) induces G2/M arrest in human cancer cells by up-regulating p21 protein expression through an p53 protein-independent cascade.中药单体延胡索甲素(YHL-14)通过非依赖 p53 蛋白的级联反应上调 p21 蛋白表达,诱导人癌细胞 G2/M 期阻滞。
J Biol Chem. 2014 Mar 7;289(10):6394-6403. doi: 10.1074/jbc.M113.513960. Epub 2014 Jan 22.